Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in IndiaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field., part of Aurobindo Pharma. FDA records under its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Eugia Pharma Specialities Limited with 2 warning letters. The most recent is a warning letter dated Aug 13, 2026: Warning letter: Aseptic processing, Sterility assurance, Environmental monitoring.
Drug approvals, 510(k) clearances, recalls and letters, 2017 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Aug 13, 2026 | Warning letter: Aseptic processing, Sterility assurance, Environmental monitoringCDER | Warning letters |
| Aug 15, 2024 | Warning letter: Data integrity, Aseptic processing, Sterility assuranceCDER | Warning letters |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata. How this page is built
